A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer

Launched by EILEEN SOULIS · Oct 6, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring biomarkers in patients with certain types of cancer, specifically those with solid tumors. Biomarkers are substances in the body that can indicate the presence or progress of disease. The study aims to understand how these biomarkers change before and after treatment, how they relate to how well a tumor responds to treatment, and to possibly discover new markers that could help diagnose or predict cancer. Participants will be asked to provide samples such as blood, urine, stools, hair follicles, or saliva, depending on their specific cancer type.

To be eligible for this study, participants must be at least 18 years old and have a confirmed diagnosis of malignant solid tumor cancer. They should be visiting the hospital for check-ups, treatments, or follow-ups. Participants will need to give their written consent and be able to follow the study rules. It's important to note that individuals with certain medical or mental health issues that would complicate the collection of samples may not be eligible. Overall, this study offers a chance to contribute to important research that could improve cancer diagnosis and treatment in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Histologically or cytologically confirmed malignant disease (solid tumour) or a diagnosis of malignant disease made using recognised clinical criteria.
• • 2. Patients who are attending for clinical assessments at presentation; during a routine hospital visit for anti-cancer therapy, radiotherapy, surgery, or for whom no immediate specific therapy is planned; or at a follow-up hospital visit.
• • 3. Written informed consent.
• • 4. Age ≥18 years.
• • 5. Able to comply with study protocol.
• Exclusion Criteria:
• • (1) Any evidence of any medical or psychiatric disorders that would, in the opinion of the investigator, be a contra indication to venesection, urine, stool or saliva collection.